Rosiglitazone and cardiovascular disease revisited
Med J Aust
.
2010 Aug 2;193(3):134-5.
doi: 10.5694/j.1326-5377.2010.tb03829.x.
Authors
Timothy M E Davis
,
Johannes B Prins
PMID:
20678037
DOI:
10.5694/j.1326-5377.2010.tb03829.x
No abstract available
Publication types
Editorial
MeSH terms
Cardiovascular Diseases / chemically induced*
Humans
Hypoglycemic Agents / adverse effects*
Rosiglitazone
Thiazolidinediones / adverse effects*
Substances
Hypoglycemic Agents
Thiazolidinediones
Rosiglitazone